New radiation method shows promise for Hard-to-Treat pituitary tumors
NCT ID NCT06826170
First seen Apr 02, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tested a new way to deliver radiation (hypofractionated stereotactic radiotherapy) to people with non-secreting pituitary adenomas that remained or came back after initial treatment. The goal was to see if this approach is safer for nearby structures like the optic nerve while still controlling tumor growth. 25 adults were treated and followed for side effects, vision changes, hormone function, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITUITARY ADENOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Neurologico C Besta
Milan, Milan, 20133, Italy
Conditions
Explore the condition pages connected to this study.